Background Adhesive capsulitis is common and can cause stiffness and pain. Diabetes and dyslipidemia are known to be associated with adhesive capsulitis. However, there is no report of any association between serum lipid profiles and adhesive capsulitis accompanied by diabetes.
Question/purpose Which serum lipid abnormalities are associated with adhesive capsulitis accompanied by diabetes? Methods This is a case-control study with two control groups. Our case group included 37 patients with newly diagnosed adhesive capsulitis accompanied by newly diagnosed diabetes who had no other diagnosed systemic diseases or rotator cuff tears. The two control groups each had 111 age-and sex-matched individuals with normal shoulder function (bilaterally pain-free, with full range of motion and no shoulder muscle weakness), no thyroid dysfunction, and no previously diagnosed systemic diseases. Individuals in the first control group had neither adhesive capsulitis nor diabetes. Individuals in the second control group had newly diagnosed diabetes without adhesive capsulitis. We evaluated any association between adhesive capsulitis accompanied by diabetes and serum lipid profile, including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, and nonhigh-density lipoprotein (nonHDL). Conditional logistic regression analysis was used to evaluate the strengths of associations between serum lipid levels and adhesive capsulitis accompanied by diabetes, as determined by odds ratios (ORs) and 95% confidence intervals (CIs). Results Low-density lipoprotein and nonHDL were associated with adhesive capsulitis accompanied by diabetes. Specifically, patients with adhesive capsulitis and diabetes had greater odds ratios of hyperlow-density lipoproteinemia when compared with individuals with neither adhesive capsulitis nor diabetes (OR, 3.19; 95% CI, 1.21-8.38; p = 0.019) and when compared with individuals without adhesive capsulitis but with newly diagnosed diabetes (OR, 5.76; 95% CI, 1.67-19.83; p = 0.005). Similarly, patients with adhesive capsulitis accompanied by Each author certifies that neither he or she, nor any member of his or her immediate family, have funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. Clinical Orthopaedics and Related Research® neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use. Each author certifies that his or her institution approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.
Introduction
Adhesive capsulitis is one of the most frequently encountered shoulder disorders in clinical practice [31] . Several characteristics have been reported as adhesive capsulitis risk factors, including age, female sex, dyslipidemia, thyroid abnormality, and diabetes [2, 14, 19] . Diabetes is the most frequently cited risk factor [9, 21] . Various studies have reported that for patients with diabetes, the lifetime risk of developing adhesive capsulitis ranges from 4.3% to 30% [3, 5, 7, 8, 29] , indicating that patients with diabetes are five to nine times more likely than the general population to develop the disorder [5, 29] . Dyslipidemia is known to occur frequently in patients who have diabetes and thyroid disorders [23, 28] .
The development of adhesive capsulitis has not been completely elucidated. The glycation process has been proposed as a diabetes-related mechanism for the development of adhesive capsulitis [6] . Previous studies have reported that dyslipidemia is associated with adhesive capsulitis [7, 27] . However, to our knowledge, no study has shown an association between serum inflammatory lipoproteins and adhesive capsulitis accompanied by diabetes. It would be helpful to understand more fully the roles of inflammatory lipoproteins in the pathogenesis of adhesive capsulitis.
Because dyslipidemia, diabetes, and thyroid disorders frequently occur together, it is necessary to determine whether any of these three variables is an independent risk factor for adhesive capsulitis [18, 27] . Lo et al. [19] reported that diabetes and hyperlipidemia are independent risk factors for adhesive capsulitis. Another study reported that after adjustment for age, sex, and dyslipidemia, diabetes is an independent risk factor for the development of adhesive capsulitis and, additionally, that hyperlipidemia is associated with a higher risk of adhesive capsulitis development [14] . However, neither of these studies specified which types of serum lipid abnormalities are associated with a higher risk of adhesive capsulitis development. Increased serum concentrations of nonhigh-density lipoprotein (nonHDL), consisting of low-density lipoprotein (LDL) and triglyceride-rich lipoproteins such as intermediate-density lipoprotein (IDL) and very-low-density lipoprotein (VLDL), induce inflammation on the arterial walls, where they cause atherosclerosis [25] . These highly atherogenic lipoproteins are called inflammatory lipoproteins [4] . One recent study reported an association between serum inflammatory lipoproteins and primary adhesive capsulitis [27] . However, we are not aware of any study that has shown an association between serum inflammatory lipoproteins and adhesive capsulitis accompanied by diabetes.
Therefore, we asked: Which serum lipid abnormalities are associated with adhesive capsulitis accompanied by diabetes?
Patients and Methods

Study Design and Setting
This was a case-control study with two control groups. We investigated all the patients who visited our clinic because of their shoulder problems from October 2009 to November 2017. Among those patients, 672 were diagnosed with adhesive capsulitis. Of these, we excluded 71 patients (11%) who had no laboratory results. Among the remaining patients, 198 had diabetes that was diagnosed at the authors' clinic or confirmed by medical history. We considered the patients who had a glycosylated hemoglobin A1c (HbA1c) level of $ 6.5% to have diabetes. We excluded from this study 161 of the 198 patients (81%) with diabetes for one or more of the following reasons: 53 patients (27%) had associated intrinsic lesions such as a rotator cuff tear, labral lesion, or biceps injury, and 108 (55%) had a history of using hypoglycemic agents prescribed for their known diabetes and/or cholesterollowering drugs prescribed for their dyslipidemia. The remaining 37 patients received their first diagnoses of diabetes during blood tests involved in diagnosing adhesive capsulitis and were included in this study. Based on blood tests, they were determined to have diabetes without combined thyroid abnormality. Patients in the case group had no history of trauma or shoulder surgery, no history of receiving surgical or drug treatment for a previously diagnosed thyroid disease, and no evidence of rotator cuff tears, as determined by MRI (20 patients) or ultrasonography (17 patients).
Adhesive capsulitis was diagnosed based on the presence of both active and passive motion restrictions of the glenohumeral joint in flexion, abduction, and internal rotation, with external rotation measured with the arm at the side restricted to < 50% of that of the normal side. The senior author (HBP) evaluated the shoulder motion of each seated patient.
Because serum lipid levels are highly affected by a person's age and sex, the two control groups were each composed of 111 age-and sex-matched individuals who visited our health promotion center for routine health checkups during the same period [10, 17] . Without exception, all individuals had a full serum lipid profile performed during same period. We selected individuals who were age-and sex-matched with the patients who had been diagnosed with adhesive capsulitis accompanied by diabetes. Each control group was, therefore, three times as large as the case group. In case-control studies, the statistical power can be increased by selecting more than one control per case, although the additional gain is small if the case:control ratio exceeds 1:4 [12, 20, 34] . We used three times as many controls as cases in each comparison because that was the maximum number of control individuals for age-and sex-matching who were available to us through the health promotion center. The inclusion criteria for the control groups were normal shoulder motion, no bilateral differences, and no shoulder symptoms. Patients in the control group had no medication history of treatment for diabetes, thyroid disease, or dyslipidemia. They also had no history of trauma or shoulder surgery. The first control group was composed of individuals with neither adhesive capsulitis nor diabetes. The second control group was composed of individuals who were newly diagnosed with diabetes during routine health checkups. This second control group was designed to eliminate any confounding effect of diabetes on serum lipid levels.
Demographic data, serum lipid levels, and the prevalence of dyslipidemia for the 37 patients with adhesive capsulitis accompanied by diabetes and 111 individuals of two control groups were matched by age and sex (Table 1) . For the patients with adhesive capsulitis, the mean duration of symptoms was 5.8 6 2.7 months; the median interval between initial examination and blood sampling was 6.0 days (interquartile range [IQR], 1.0-8.0); and the median interval between initial examination and ultrasound or MRI was 5.7 days (IQR, 0.0-7.1).
In the scale and categorical analyses, body mass index was not associated with adhesive capsulitis accompanied by diabetes when we compared individuals in all three study groups ( Table 2) . We found that HbA1c levels were associated with adhesive capsulitis accompanied by diabetes when comparing the patients in the case group to individuals who had neither adhesive capsulitis nor diabetes; HbA1c levels were not associated with individuals newly diagnosed with diabetes who did not have adhesive capsulitis (Table 2) .
We studied the following serum lipid profiles: total cholesterol, triglycerides, LDL, and high-density lipoprotein (HDL). NonHDL is calculated by subtracting HDL from total cholesterol [26] . We used the dyslipidemia criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines [13] . The categorical data, categorizing the serum lipid as either with or without abnormality according to the previously suggested cut-off values, included the following dyslipidemias: hypercholesterolemia (total cholesterol of $ 200 mg/dL), hyperlow-density lipoproteinemia (LDL of $ 100 mg/dL), hypertriglyceridemia (triglycerides of $ 150 mg/dL), hypohigh-density lipoproteinemia (HDL of < 40 mg/dL for men and < 50 mg/dL for women), and hypernonhigh-density lipoproteinemia (nonHDL of $ 130 mg/dL). Serum lipid profile examinations were done after 8-hour fasting followed by venipuncture.
The institutional review board of the Gyeongsang National University Hospital (GNUH 2015-05-012) approved this study.
Data Analysis
We calculated the odds ratios (ORs) and 95% confidence intervals (95% CIs) to identify any association between serum lipid levels and diabetes and adhesive capsulitis, using univariate conditional logistic regression analysis. Significance was set at p < 0.05. Continuous data were evaluated for total cholesterol, LDL, HDL, triglycerides, and nonHDL. Categorical data were evaluated for hypercholesterolemia, hyperlow-density lipoproteinemia, hypohigh-density lipidemia, hypertriglyceridemia, and hypernonhigh-density lipoproteinemia. We did not perform multivariable conditional logistic regression analysis because the variance inflation factor was 10.2 and the condition index was 28.3 for multicollinearity among lipid profiles. Therefore, we considered multicollinearity to be present among the serum lipid profiles. All statistical analyses were performed with use of PASW Statistics, version 24.0 (IBM SPSS Statistics for Windows, Version 24.0; IBM Corp, Armonk, NY, USA).
Results
In our comparison of individuals with adhesive capsulitis and diabetes and those with neither adhesive capsulitis nor diabetes, we found that adhesive capsulitis accompanied by diabetes was very slightly associated with total Interestingly, neither HDL nor hypohigh-density lipoproteinemia were associated with adhesive capsulitis accompanied by diabetes compared with individuals with neither adhesive capsulitis nor diabetes (Table 3) . Highdensity lipoprotein, hypohigh-density lipoproteinemia, triglycerides, and hypertriglyceridemia were not associated with adhesive capsulitis accompanied by diabetes in a comparison involving individuals with newly diagnosed diabetes without adhesive capsulitis (Table 4) .
Discussion
Diabetes and dyslipidemia are known to be associated with adhesive capsulitis. However, to our knowledge, no study has shown an association between serum inflammatory lipoproteins and adhesive capsulitis accompanied by diabetes. We, therefore, aimed to determine if there are associations between serum lipid profiles and adhesive capsulitis accompanied by diabetes, of which inflammatory lipoproteins are associated factors. It would probably be useful to understand further the pathophysiology of adhesive capsulitis involved in an inflammatory process. The current study had several limitations. We did not evaluate the regional prevalence of and ethnic differences in serum lipid profiles. We did not evaluate, with either ultrasound or MRI, the rotator cuff status of the patients in the control groups. However, we did include a control group whose members had full shoulder motion and no shoulder symptoms. The current study did not completely exclude the unlikely possibility of a relationship between lipid abnormalities and rotator cuff tears. Although some members of the control group had asymptomatic rotator cuff tears, we are still confident that their serum lipid levels were not lower than those of the patients with intact rotator cuffs because we controlled for other influencing factors. One previous study of serum lipid levels of patients with rotator cuff injuries reported that their serum cholesterol levels were higher than those of patients with intact shoulders [1] . Another study reported that the mean serum cholesterol levels of two such groups were at the same level [22] . Therefore, any incidence of asymptomatic rotator cuff tears in the current control group would not influence the results in the opposite direction. The case group population in this study is relatively small. Nonetheless, we believe that the study population is of sufficient size, and the statistics bear this out, in that we were able to detect between-group differences. Future studies are needed to try to replicate our findings, and to see whether they generalize to other populations. Because this was a cross-sectional study, we could not determine any association between serum lipid profiles and the different stages of adhesive capsulitis. Any timedependent relationship between the stages of adhesive capsulitis and the serum lipid profiles remains to be determined. Finally, even though this study adjusted for diabetic effects on serum lipids, we did not have data regarding duration of the hyperglycemic condition either in the patients with adhesive capsulitis accompanied by diabetes or in individuals without adhesive capsulitis but with newly diagnosed diabetes. Therefore, we were unable to rule out completely whether dyslipidemia is affected by diabetes.
We found that hyperlow-density lipoproteinemia and hypernonhigh-density lipoproteinemia are associated with adhesive capsulitis accompanied by diabetes. Regarding serum lipid abnormalities in adhesive capsulitis, one previous study has reported elevated serum triglycerides and total cholesterol levels in patients with primary adhesive capsulitis [7] . Another study has reported that inflammatory lipoproteinemias, especially hyperlow-density lipoproteinemia and hypernonhigh-density lipoproteinemia, have an association with primary adhesive capsulitis [27] . A longitudinal study, using national health insurance data from Taiwan without determining each subject's serum lipid profile, has reported hyperlipidemia as an independent risk factor for diabetes and adhesive capsulitis [19] . According to the results of those previous studies and of this current study, dyslipidemia is strongly associated not only with primary adhesive capsulitis, but also with adhesive capsulitis accompanied by diabetes.
Inflammatory lipoproteins, such as LDL and nonHDL, are well-known risk factors for atherosclerotic cardiovascular diseases [26] . According to the results in both our case-control comparisons, LDL, hyperlow-density lipoproteinemia, nonHDL and hypernonhigh-density lipoproteinemia were associated with adhesive capsulitis accompanied by diabetes. Body mass index and serum HbA1c level, which are known to be associated with diabetes severity, were not associated with patients with adhesive capsulitis accompanied by diabetes. This suggests that inflammatory lipoproteins are independent risk factors for adhesive capsulitis accompanied by diabetes. Although a variety of abnormalities have been described in adhesive capsulitis, the underlying pathophysiological process in adhesive capsulitis involves synovial inflammation with subsequent joint capsule fibrosis. The characteristic histological finding of adhesive capsulitis is inflammatory contracture of the capsule with acute vasculitis [30, 33] . Increased expression of the intercellular adhesion molecule-1 (ICAM-1) has been reported in the joint capsules of patients with adhesive capsulitis [16] . The increased expressions of cytokines, such as transforming growth factor beta 1 (TGF-b1) and connective tissue growth factor, have been reported in synoviocytes treated with ICAM-1, but not in synoviocytes not treated with ICAM-1 [16] . Increased expression of TGF-b and platelet-derived growth factor (PDGF) has been identified in capsular tissues from patients with adhesive capsulitis, suggesting that those cytokines, which are well-known fibrosis-inducing factors, contribute to capsular fibrosis [32] . Those results are similar to findings regarding atherosclerosis. Inflammatory lipoproteins induce vascular inflammation and immune reactions. Low-density lipoprotein is prone to oxidative modification by reactive oxygen species, resulting in oxidized LDL, which can induce endothelial cell activation in vessel walls [32] . The endothelial cell activation leads to the expressions of ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1), which attract inflammatory cells and inflammation-related cytokines [15] .
This study suggests that inflammatory lipoproteinemias and related inflammatory processes of adhesive capsulitis are involved in molecular mechanisms that are similar to those seen in atherosclerotic cardiovascular disease. A cohort study reported that a 1 mg/dL decrease in the total cholesterol serum level was associated with a 1.5% reduction in coronary heart disease mortality [11] . An LDLlowering simvastatin study reported that each additional 1% reduction in LDL reduced major coronary events by 1.7% [24] . These frequently cited lipid studies have shown consistently that small differences in serum total cholesterol or lipoprotein levels cause changes in the incidence of cardiovascular events and mortality. Questions remain about the possible need for routine serum lipid profile screening and for improvement of serum lipoprotein levels using lipid-lowering drugs in patients with adhesive capsulitis accompanied by diabetes.
In conclusion, inflammatory lipoproteinemias, particularly hyperlow-density lipoproteinemia and hypernonhighdensity lipoproteinemia, are associated with adhesive capsulitis accompanied by diabetes. Further research is needed to evaluate whether inflammatory lipoproteinemias are a cause, a related cofactor, or an aggravating factor in the development of adhesive capsulitis with diabetes.
